title: In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses.
abstract: The in vitro antifungal activity of luliconazole, a novel topical imidazole, against pathogenic fungi implicated in dermatomycoses was studied. A total of 91 clinical isolates, consisting of 59 Trichophyton rubrum isolates, 26 T. mentagrophytes isolates, 1 Epidermophyton floccosum isolate, and 5 Candida albicans isolates were tested by the broth microdilution method, employing lanoconazole, terbinafine, and bifonazole as reference drugs. The minimum inhibitory concentrations (MICs) of luliconazole against T. rubrum and T. mentagrophytes were in the range of 0.00012-0.004 microg/ml and 0.00024-0.002 microg/ml, respectively. The MIC90 of luliconazole for these two species of dermatophytes was the same, at 0.001 microg/ml, and these values were 4 times, 30 times, and more than 1000 times lower than those of lanoconazole, terbinafine, and bifonazole, respectively. Similarly, the 1 isolate of E. floccosum tested was inhibited by luliconazole with an MIC of 0.001 microg/ml. Luliconazole also proved to be very potent against C. albicans (MIC range, 0.031-0.25 microg/ml), nearly on par, in terms of efficacy, with lanoconazole (0.063-0.25 microg/ml) and more potent than terbinafine (2->64 microg/ml) and bifonazole (0.5-4 microg/ml). These results showed that luliconazole was very potent in vitro against pathogenic fungi isolated from patients with dermatomycoses, and these findings emphasized the utility of luliconazole for the topical management of this condition.
authors.affiliation: Research Center, Nihon Nohyaku Co., Ltd., 345 Oyamada-cho, Kawachi-Nagano, Osaka, 586-0094, Japan. koga-hiroyasu@nichino.co.jp
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Koga
authors.forename: Yuri
authors.initials: Y
authors.lastname: Tsuji
authors.forename: Kazuyoshi
authors.initials: K
authors.lastname: Inoue
authors.forename: Kazuo
authors.initials: K
authors.lastname: Kanai
authors.forename: Toshiro
authors.initials: T
authors.lastname: Majima
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Kasai
authors.forename: Katsuhisa
authors.initials: K
authors.lastname: Uchida
authors.forename: Hideyo
authors.initials: H
authors.lastname: Yamaguchi
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology*; D003881:Dermatomycoses / Q000382:microbiology*; D005658:Fungi / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; C029899:imidazole